Genelux (GNLX) Current Leases (2022 - 2026)

Genelux (GNLX) recorded quarterly Current Leases of $316000.0 in Q1 2026, down 26.0% quarter-over-quarter from $427000.0 in Q4 2025.

Genelux (GNLX) Current Leases (2022 - 2026) Analysis & Trends

Genelux's Current Leases history runs 5 years deep, the most recent figure standing at $316000.0 for Q1 2026.

  • In Q1 2026, Current Leases changed N/A year-over-year to $316000.0; the TTM figure through Mar 2026 stood at $316000.0 (changed N/A YoY), while the FY2025 annual figure was $427000.0, up 29.79% from the prior year.
  • Current Leases was $316000.0 for Q1 2026 at Genelux, down from $427000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $653000.0 in Q4 2023 to a low of $266000.0 in Q4 2022.
  • Historically, Current Leases has averaged $432363.6 across 5 years, with a median of $415000.0 in 2024.
  • The sharpest annual moves came in 2023 and 2024: Current Leases jumped 145.49% in 2023, then sank 49.62% in 2024.
  • A 5-year view of Current Leases shows it stood at $266000.0 in 2022, then soared by 145.49% to $653000.0 in 2023, then tumbled by 49.62% to $329000.0 in 2024, then grew by 29.79% to $427000.0 in 2025, then retreated by 26.0% to $316000.0 in 2026.
  • The last three Current Leases figures came in at $316000.0 (Q1 2026), $427000.0 (Q4 2025), and $354000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 83,991.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 7.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Genelux 129.36 Mn 129.36 Mn - 316,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 316,000.00
Dec 31, 2025 427,000.00
Sep 30, 2025 354,000.00
Jun 30, 2025 345,000.00
Dec 31, 2024 329,000.00
Sep 30, 2024 415,000.00
Jun 30, 2024 500,000.00
Mar 31, 2024 584,000.00
Dec 31, 2023 653,000.00
Sep 30, 2023 567,000.00
Dec 31, 2022 266,000.00